Fitch Rates Watson Pharmaceuticals Term Loan Facility 'BBB'
News | 27 June 2012
Fitch anticipates that Watson will use proceeds from the new term loan facility to finance a portion of the cost to acquire Actavis Group, a privately-held global generic pharmaceutical company, for an upfront payment of Euro 4.25 billion plus ...
Click on the link to read the full article at MarketWatch (press release)
(This link will open in a new window)
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
